The Global Burden of Mental, Neurological and Substance Use Disorders: an Analysis from the Global Burden of Disease Study 2010

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Feb 7

PMID 25658103

Citations 469

Authors

Harvey A Whiteford

Alize J Ferrari

Louisa Degenhardt

Valery Feigin

Theo Vos

Affiliations

Soon will be listed here.

Abstract

Background: The Global Burden of Disease Study 2010 (GBD 2010), estimated that a substantial proportion of the world's disease burden came from mental, neurological and substance use disorders. In this paper, we used GBD 2010 data to investigate time, year, region and age specific trends in burden due to mental, neurological and substance use disorders.

Method: For each disorder, prevalence data were assembled from systematic literature reviews. DisMod-MR, a Bayesian meta-regression tool, was used to model prevalence by country, region, age, sex and year. Prevalence data were combined with disability weights derived from survey data to estimate years lived with disability (YLDs). Years lost to premature mortality (YLLs) were estimated by multiplying deaths occurring as a result of a given disorder by the reference standard life expectancy at the age death occurred. Disability-adjusted life years (DALYs) were computed as the sum of YLDs and YLLs.

Results: In 2010, mental, neurological and substance use disorders accounted for 10.4% of global DALYs, 2.3% of global YLLs and, 28.5% of global YLDs, making them the leading cause of YLDs. Mental disorders accounted for the largest proportion of DALYs (56.7%), followed by neurological disorders (28.6%) and substance use disorders (14.7%). DALYs peaked in early adulthood for mental and substance use disorders but were more consistent across age for neurological disorders. Females accounted for more DALYs in all mental and neurological disorders, except for mental disorders occurring in childhood, schizophrenia, substance use disorders, Parkinson's disease and epilepsy where males accounted for more DALYs. Overall DALYs were highest in Eastern Europe/Central Asia and lowest in East Asia/the Pacific.

Conclusion: Mental, neurological and substance use disorders contribute to a significant proportion of disease burden. Health systems can respond by implementing established, cost effective interventions, or by supporting the research necessary to develop better prevention and treatment options.

Citing Articles

Socio-demographic factors associated with mental health disorders among rural women in Mymensingh, Bangladesh.

Khan R, Akter F, Rahman M, Amin N, Rahman M, Winch P Front Psychiatry. 2025; 16:1446473.

PMID: 40041695 PMC: 11876128. DOI: 10.3389/fpsyt.2025.1446473.

Burden of Substance Use Disorders in the Middle East and North Africa from 1990 to 2019.

Darijani S, Seyedmirzaei H, Nakhostin-Ansari A, Menbari-Oskouie I, Ghaseminejad-Raeini A, Nasoori H Balkan Med J. 2025; 42(2):138-149.

PMID: 40033654 PMC: 11881533. DOI: 10.4274/balkanmedj.galenos.2025.2024-11-61.

No gender difference in cardiac interoceptive accuracy: Potential psychophysiological contributors in heartbeat counting task.

Haruki Y, Kaneko K, Ogawa K BMC Psychol. 2025; 13(1):176.

PMID: 40022207 PMC: 11871792. DOI: 10.1186/s40359-025-02432-6.

Neurofind: using deep learning to make individualised inferences in brain-based disorders.

Vieira S, Baecker L, Pinaya W, Garcia-Dias R, Scarpazza C, Calhoun V Transl Psychiatry. 2025; 15(1):69.

PMID: 40016187 PMC: 11868583. DOI: 10.1038/s41398-025-03290-x.

Comparison of logistic regression and machine learning methods for predicting depression risks among disabled elderly individuals: results from the China Health and Retirement Longitudinal Study.

Hong S, Lu B, Wang S, Jiang Y BMC Psychiatry. 2025; 25(1):128.

PMID: 39953491 PMC: 11829540. DOI: 10.1186/s12888-025-06577-x.

References

Murray C, ACHARYA A . Understanding DALYs (disability-adjusted life years). J Health Econ. 1997; 16(6):703-30. DOI: 10.1016/s0167-6296(97)00004-0. View

Cheng A . Case definition and culture: Are people all the same?. Br J Psychiatry. 2001; 179:1-3. DOI: 10.1192/bjp.179.1.1. View

Saha S, Chant D, Welham J, McGrath J . A systematic review of the prevalence of schizophrenia. PLoS Med. 2005; 2(5):e141. PMC: 1140952. DOI: 10.1371/journal.pmed.0020141. View

Diop A, Hesdorffer D, Logroscino G, Hauser W . Epilepsy and mortality in Africa: a review of the literature. Epilepsia. 2006; 46 Suppl 11:33-5. DOI: 10.1111/j.1528-1167.2005.00405.x. View

Wang P, Aguilar-Gaxiola S, Alonso J, Angermeyer M, Borges G, Bromet E . Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys. Lancet. 2007; 370(9590):841-50. PMC: 2847360. DOI: 10.1016/S0140-6736(07)61414-7. View

Wang P, Angermeyer M, Borges G, Bruffaerts R, Chiu W, de Girolamo G . Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2008; 6(3):177-85. PMC: 2174579. View

Yang L, Link B . Comparing diagnostic methods for mental disorders in China. Lancet. 2009; 373(9680):2002-4. DOI: 10.1016/S0140-6736(09)61091-6. View

Ferrari A, Baxter A, Whiteford H . A systematic review of the global distribution and availability of prevalence data for bipolar disorder. J Affect Disord. 2010; 134(1-3):1-13. DOI: 10.1016/j.jad.2010.11.007. View

Degenhardt L, Bucello C, Calabria B, Nelson P, Roberts A, Hall W . What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug Alcohol Depend. 2011; 117(2-3):85-101. DOI: 10.1016/j.drugalcdep.2010.11.032. View

10.

Jorm A . Mental health literacy: empowering the community to take action for better mental health. Am Psychol. 2011; 67(3):231-43. DOI: 10.1037/a0025957. View

11.

Murray C, Ezzati M, Flaxman A, Lim S, Lozano R, Michaud C . GBD 2010: design, definitions, and metrics. Lancet. 2012; 380(9859):2063-6. DOI: 10.1016/S0140-6736(12)61899-6. View

12.

Wang H, Dwyer-Lindgren L, Lofgren K, Rajaratnam J, Marcus J, Levin-Rector A . Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2071-94. DOI: 10.1016/S0140-6736(12)61719-X. View

13.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

14.

Salomon J, Wang H, Freeman M, Vos T, Flaxman A, Lopez A . Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010. Lancet. 2012; 380(9859):2144-62. DOI: 10.1016/S0140-6736(12)61690-0. View

15.

Vos T, Flaxman A, Naghavi M, Lozano R, Michaud C, Ezzati M . Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2163-96. PMC: 6350784. DOI: 10.1016/S0140-6736(12)61729-2. View

16.

Murray C, Vos T, Lozano R, Naghavi M, Flaxman A, Michaud C . Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2197-223. DOI: 10.1016/S0140-6736(12)61689-4. View

17.

Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

18.

Crump C, Winkleby M, Sundquist K, Sundquist J . Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013; 170(3):324-33. DOI: 10.1176/appi.ajp.2012.12050599. View

19.

Whiteford H, Ferrari A, Baxter A, Charlson F, Degenhardt L . How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?. Curr Opin Psychiatry. 2013; 26(4):376-83. DOI: 10.1097/YCO.0b013e328361e60f. View

20.

Lawrence D, Hancock K, Kisely S . The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ. 2013; 346:f2539. PMC: 3660620. DOI: 10.1136/bmj.f2539. View